BioStem Technologies, Inc.

OTCPK:BSEM Stock Report

Market Cap: US$282.5m

BioStem Technologies Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Jason Matuszewski

Chief executive officer

US$275.0k

Total compensation

CEO salary percentage100.0%
CEO tenure10.2yrs
CEO ownershipn/a
Management average tenure6.7yrs
Board average tenure3.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jason Matuszewski's remuneration changed compared to BioStem Technologies's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$16m

Jun 30 2024n/an/a

US$8m

Mar 31 2024n/an/a

-US$1m

Dec 31 2023US$275kUS$275k

-US$8m

Sep 30 2023n/an/a

-US$12m

Jun 30 2023n/an/a

-US$11m

Mar 31 2023n/an/a

-US$8m

Dec 31 2022US$8mUS$200k

-US$7m

Compensation vs Market: Jason's total compensation ($USD275.00K) is below average for companies of similar size in the US market ($USD1.38M).

Compensation vs Earnings: Jason's compensation has been consistent with company performance over the past year.

CEO

Jason Matuszewski (38 yo)

10.2yrs

Tenure

US$275,000

Compensation

Mr. Jason V. Matuszewski is Chief Executive Officer of BioStem Technologies, Inc. since October 22, 2019 and served as Chairman of BioStem Technologies, Inc. since October 22, 2019 and its President and Se...

Leadership Team

NamePositionTenureCompensationOwnership
Jason Matuszewski
CEO, President10.2yrsUS$275.00kno data
Michael Fortunato
Chief Financial Officer2.2yrsUS$455.00kno data
Andrew Van Vurst
COO & Directorno dataUS$275.00kno data
Neal Bhattacharya
Vice President of Marketingless than a yearno datano data
David Woynarowski
Chief Medical Officer8.8yrsno datano data
Larry Jones
Chief Revenue Officer6.8yrsno datano data
Irmgard Huber
International Medical Advisor & Interim Chief Medical Officer6.7yrsno datano data
Shawn McCarrey
Chief Commercial Officerless than a yearno datano data

6.7yrs

Average Tenure

47.5yo

Average Age

Experienced Management: BSEM's management team is seasoned and experienced (6.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jason Matuszewski
CEO, Presidentno dataUS$275.00kno data
Andrew Van Vurst
COO & Director8.8yrsUS$275.00kno data
Thomas Dugan
Chairman of the Boardless than a yearUS$60.00kno data
Patrick Daly
Independent Directorless than a yearUS$60.00kno data
Brandon Poe
Independent Director2.3yrsUS$60.00kno data
Daniel Shelly
Member of Scientific Advisory Board3.7yrsno datano data
Shaun Opie
Member of Scientific Advisory Board3.7yrsno datano data
Kenneth Warrington
Chairman of Scientific Advisory Board & Director3.7yrsUS$45.00kno data
Jeffrey Harrison
Member of Scientific Advisory Board3.7yrsno datano data

3.7yrs

Average Tenure

54yo

Average Age

Experienced Board: BSEM's board of directors are considered experienced (3.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 23:13
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioStem Technologies, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bradley SorensenZacks Small-Cap Research